Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Foteinos-Ioannis D. Dimitrakopoulos"'
Autor:
Foteinos-Ioannis D. Dimitrakopoulos, Anna G. Antonacopoulou, Anastasia E. Kottorou, Melpomeni Kalofonou, Nikolaos Panagopoulos, Dimitrios Dougenis, Thomas Makatsoris, Vasiliki Tzelepi, Angelos Koutras, Haralabos P. Kalofonos
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
BackgroundImmune system-related receptors CD40 (tumor necrosis factor receptor superfamily member 5), BAFFR (tumor necrosis factor receptor superfamily member 13C), and LTβR (tumor necrosis factor receptor superfamily member 3) play a pivotal role i
Externí odkaz:
https://doaj.org/article/c8a31c79958046baaea54e62931e3ee1
Autor:
Foteinos-Ioannis D. Dimitrakopoulos, Anna G. Antonacopoulou, Anastasia E. Kottorou, Nikolaos Panagopoulos, Fotini Kalofonou, Fotios Sampsonas, Chrisoula Scopa, Melpomeni Kalofonou, Angelos Koutras, Thomas Makatsoris, Dimitrios Dougenis, Helen Papadaki, Malcolm Brock, Haralabos P. Kalofonos
Publikováno v:
Scientific Reports, Vol 9, Iss 1, Pp 1-12 (2019)
Abstract A growing number of studies has shed light on the role of the NF-κΒ in non-small-cell lung cancer (NSCLC). To address the significance of major effectors of the NF-κΒ alternative pathway, we investigated the relationship between NF-κΒ2
Externí odkaz:
https://doaj.org/article/90d7b523d73d42dd8591096c779df15c
Autor:
Foteinos-Ioannis D. Dimitrakopoulos, Eleni Kourea, George Nasioulas, Eirini Papadopoulou, Achilles Nikolakopoulos, Despoina Spyropoulou, Anastasia Kottorou, Andreas Karatzas, Haralabos P. Kalofonos, Angelos Koutras
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 12 (2020)
Immunotherapy may result in long-lasting exceptional clinical responses, the molecular background of which is inadequately understood. Here, we present the case of a 63-year-old patient with a past medical history of renal cancer who relapsed many ye
Externí odkaz:
https://doaj.org/article/1b8c4ddadd5b4d9d9bb369423fecc871
Autor:
Haralabos P. Kalofonos, Melpomeni Kalofonou, Anastasia E. Kottorou, Foteinos-Ioannis D. Dimitrakopoulos
Supplementary Table S2. Published studies on genetic variations of NF-κB family members and their clinical significance in NSCLC.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b1c82c87ae3fcad35c49c464821cd3c
https://doi.org/10.1158/0008-5472.22425417.v1
https://doi.org/10.1158/0008-5472.22425417.v1
Autor:
Haralabos P. Kalofonos, Melpomeni Kalofonou, Anastasia E. Kottorou, Foteinos-Ioannis D. Dimitrakopoulos
Supplementary Figure S1. Hallmarks of lung cancer influenced by NF-κB activity.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6210ba999de79b46629e6b6e33336338
https://doi.org/10.1158/0008-5472.22425423
https://doi.org/10.1158/0008-5472.22425423
Autor:
Haralabos P. Kalofonos, Melpomeni Kalofonou, Anastasia E. Kottorou, Foteinos-Ioannis D. Dimitrakopoulos
Thirty-four years since its discovery, NF-κB remains a transcription factor with great potential for cancer therapy. However, NF-κB–targeted therapies have yet to find a way to be clinically translatable. Here, we focus exclusively on the role of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::862f11defaddefc1eeefd9caa436adb8
https://doi.org/10.1158/0008-5472.c.6512031.v1
https://doi.org/10.1158/0008-5472.c.6512031.v1
Autor:
Sofia Nikou, Marina Arbi, Foteinos-Ioannis D. Dimitrakopoulos, Argiro Kalogeropoulou, Christina Geramoutsou, Vasiliki Zolota, Haralabos P. Kalofonos, Stavros Taraviras, Zoi Lygerou, Vasiliki Bravou
Publikováno v:
Clinical and experimental medicine.
Ras suppressor-1 (RSU1), originally described as a suppressor of Ras oncogenic transformation, localizes to focal adhesions interacting with the ILK-PINCH-PARVIN (IPP) complex that exerts a well-established oncogenic role in cancer. However, RSU1 imp